|
|
||||||||
Insensitivity in Human Trophoblast Cells1
a Program in Development and Fetal Health, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and the Departments of Molecular and Medical Genetics, and Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada M5G 1X5
b Department of Anatomy, University of California, San Francisco, California 94143
During pregnancy, trophoblast cells of the placenta contact maternal immune cells and yet are protected from attack. One mechanism that may account for this is that trophoblasts show altered expression of major histocompatibility complex (MHC) antigens. The gene for human leukocyte antigen G (HLA-G), a nonclassical gene, is expressed at high levels in trophoblast. Unlike other MHC class I genes, the HLA-G gene lacks an interferon (IFN) response element. Moreover, we demonstrate here that IFN, which regulates classical MHC class I genes in other cell types, does not affect these genes in trophoblast, owing to inactivation of an IFN
signaling pathway. Trophoblast cells (JEG-3 and JAR) were found to be selectively refractory to IFN. Specifically, although IFN
induced the transcription factors STAT1, STAT2, and IFN regulatory factor-1, and a protective response against encephalomyocarditis virus, it failed to protect the cells from vesicular stomatitis virus, activate a transfected MHC class I gene promoter, and induce the transcription factor IFN-stimulated gene factor (ISGF)-3. The lack of ISGF3 DNA-binding activity apparently was due to diminished p48/ISGF3
subunit activity since ISGF3 DNA-binding activity and IFN
induction of MHC class I promoter activity were reconstituted by p48/ISGF3
supplementation. These data indicate that a specific IFN signaling pathway is inactive in JEG-3 trophoblast cells because of altered activity of p48/ISGF3
, and they suggest IFN insensitivity as a mechanism that may help promote feto-placental survival.
2 Correspondence: James C. Cross, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Room 880, 600 University Ave., Toronto, ON, Canada M5G 1X5. FAX: 416 586 8588; cross{at}mshri.on.ca
3 Current address: Hadassah-Hebrew University Medical Center, Department of Obstetrics and Gynecology, Hadassah Mount Scopus, P.O.B. 24035, Jerusalem, 91240 Israel.
This article has been cited by other articles:
![]() |
S.J. Bacon, S.A. Ellis, and D.F. Antczak Control of Expression of Major Histocompatibility Complex Genes in Horse Trophoblast Biol Reprod, June 1, 2002; 66(6): 1612 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fisher, O. Genbacev, E. Maidji, and L. Pereira Human Cytomegalovirus Infection of Placental Cytotrophoblasts In Vitro and In Utero: Implications for Transmission and Pathogenesis J. Virol., August 1, 2000; 74(15): 6808 - 6820. [Abstract] [Full Text] |
||||
![]() |
A. C. Morris, W. E. Spangler, and J. M. Boss Methylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control J. Immunol., April 15, 2000; 164(8): 4143 - 4149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lefebvre, S. Berrih-Aknin, F. Adrian, P. Moreau, S. Poea, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-beta J. Biol. Chem., February 23, 2001; 276(9): 6133 - 6139. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiao, L. Wang, X. Yang, T. Chen, D. Hodge, P. F. Johnson, and W. Farrar CCAAT/Enhancer-binding Protein beta Mediates Interferon-gamma -induced p48 (ISGF3-gamma ) Gene Transcription in Human Monocytic Cells J. Biol. Chem., June 22, 2001; 276(26): 23275 - 23281. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |